Compagnie Lombard Odier SCmA’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-180
| Closed | -$186K | – | 535 |
|
|
2018
Q3 | $186K | Hold |
180
| – | – | 0.01% | 296 |
|
|
2018
Q2 | $165K | Hold |
180
| – | – | 0.01% | 301 |
|
|
2018
Q1 | $175K | Sell |
180
-180
| -50% | -$175K | 0.01% | 315 |
|
|
2017
Q4 | $162K | Buy |
360
+180
| +100% | +$81K | ﹤0.01% | 418 |
|
|
2017
Q3 | $74K | Hold |
180
| – | – | ﹤0.01% | 475 |
|
|
2017
Q2 | $63K | Hold |
180
| – | – | ﹤0.01% | 485 |
|
|
2017
Q1 | $92K | Buy |
180
+80
| +80% | +$40.9K | ﹤0.01% | 458 |
|
|
2016
Q4 | $35K | Hold |
100
| – | – | ﹤0.01% | 647 |
|
|
2016
Q3 | $53K | Hold |
100
| – | – | ﹤0.01% | 670 |
|
|
2016
Q2 | $56K | Buy |
100
+60
| +150% | +$33.6K | ﹤0.01% | 648 |
|
|
2016
Q1 | $19K | Hold |
40
| – | – | ﹤0.01% | 830 |
|
|
2015
Q4 | $26K | Buy |
+40
| New | +$26K | ﹤0.01% | 765 |
|